Block G - Search Results

1

Insulin-like growth factor-1 and growth hormone (GH) levels in canine cerebrospinal fluid are unaffected by GH or GH secretagogue (MK-0677) administration.

Prahalada S, Block G, Handt L, DeBurlet G, Cahill M, Hoe CM, van Zwieten MJ. Prahalada S, et al. Among authors: block g. Horm Metab Res. 1999 Feb-Mar;31(2-3):133-7. doi: 10.1055/s-2007-978710. Horm Metab Res. 1999. PMID: 10226793

2

Improvement in migraine-specific quality of life in a clinical trial of rizatriptan.

Santanello NC, Polis AB, Hartmaier SL, Kramer MS, Block GA, Silberstein SD. Santanello NC, et al. Among authors: block ga. Cephalalgia. 1997 Dec;17(8):867-72; discussion 800. doi: 10.1046/j.1468-2982.1997.1708867.x. Cephalalgia. 1997. PMID: 9453276 Clinical Trial.

3

Validation of a migraine work and productivity loss questionnaire for use in migraine studies.

Davies GM, Santanello N, Gerth W, Lerner D, Block GA. Davies GM, et al. Among authors: block ga. Cephalalgia. 1999 Jun;19(5):497-502. doi: 10.1046/j.1468-2982.1999.019005497.x. Cephalalgia. 1999. PMID: 10403065 Clinical Trial.

4

Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group.

Teall J, Tuchman M, Cutler N, Gross M, Willoughby E, Smith B, Jiang K, Reines S, Block G. Teall J, et al. Among authors: block g. Headache. 1998 Apr;38(4):281-7. doi: 10.1046/j.1526-4610.1998.3804281.x. Headache. 1998. PMID: 9595867 Clinical Trial.

5

Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine.

Gijsman H, Kramer MS, Sargent J, Tuchman M, Matzura-Wolfe D, Polis A, Teall J, Block G, Ferrari MD. Gijsman H, et al. Among authors: block g. Cephalalgia. 1997 Oct;17(6):647-51. doi: 10.1046/j.1468-2982.1997.1706647.x. Cephalalgia. 1997. PMID: 9350384 Clinical Trial.

6

Pilot study of MK-462 in migraine.

Cutler NR, Claghorn J, Sramek JJ, Block G, Panebianco D, Cheng H, Olah TV, Reines SA. Cutler NR, et al. Among authors: block g. Cephalalgia. 1996 Apr;16(2):113-6. doi: 10.1046/j.1468-2982.1996.1602113.x. Cephalalgia. 1996. PMID: 8665577 Clinical Trial.

7

Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group.

Tfelt-Hansen P, Teall J, Rodriguez F, Giacovazzo M, Paz J, Malbecq W, Block GA, Reines SA, Visser WH. Tfelt-Hansen P, et al. Among authors: block ga. Headache. 1998 Nov-Dec;38(10):748-55. doi: 10.1046/j.1526-4610.1998.3810748.x. Headache. 1998. PMID: 11284463 Clinical Trial.

8

Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group.

Goldstein J, Ryan R, Jiang K, Getson A, Norman B, Block GA, Lines C. Goldstein J, et al. Among authors: block ga. Headache. 1998 Nov-Dec;38(10):737-47. doi: 10.1046/j.1526-4610.1998.3810737.x. Headache. 1998. PMID: 11284462 Clinical Trial.

9

Guidelines for controlled trials of drugs in migraine: second edition.

Tfelt-Hansen P, Block G, Dahlöf C, Diener HC, Ferrari MD, Goadsby PJ, Guidetti V, Jones B, Lipton RB, Massiou H, Meinert C, Sandrini G, Steiner T, Winter PB; International Headache Society Clinical Trials Subcommittee. Tfelt-Hansen P, et al. Among authors: block g. Cephalalgia. 2000 Nov;20(9):765-86. doi: 10.1046/j.1468-2982.2000.00117.x. Cephalalgia. 2000. PMID: 11167908 No abstract available.

10

Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group.

Block G, Liss C, Reines S, Irr J, Nibbelink D. Block G, et al. Eur Neurol. 1997;37(1):23-7. doi: 10.1159/000117399. Eur Neurol. 1997. PMID: 9018028 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

726 results

Search Page